Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
3 Thoughts on the FDA’s Final LDTs Rule
Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs
Point-of-Care Tests Likely to Become Bigger Factor in Lab Business Moving Forward
From - Laboratory Industry Report
For decades, the mechanics of laboratory testing have been at a physical remove from the bulk of health care delivery. A blood draw or tissue sample is performed on a patient at one site and…
HHS’ Top Ten Management Problems Include Labs
By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG's FY 2015 Top Management and Performance Challenges target clinical laboratories among other providers as a necessary focus of efforts to fight fraud, abuse and waste in Medicare. Specifically, the...
Special Focus: The Rise of Liquid Biopsy Testing
From - Diagnostic Testing & Emerging Technologies
Early in the year DTET spoke to experts that predicted 2015 would be the year that liquid biopsy technology penetrates the clinical oncology market. These predictions did not disappoint. A near continuous stream of publications, conference presentations, and…
Avellino Expands Gene Testing for LASIK Prep Test
By Ron Shinkman, Editor, Laboratory Industry Report California-based Avellino Labs has expanded its molecular testing menu for patients who are considering lasik or other elective surgeries that will alter the structure of their eyes. Elective laser eye surgery,...
CMS Estimates 2016 PFS to Have Positive Impact on Pathology, Independent Labs
By Kelly A. Briganti, Editorial Director, G2 Intelligence This past year brought many unwelcome reimbursement developments—most notably, the initial steps to implement PAMA; but it also included the repeal of the dreaded Sustainable Growth Rate. The Centers for...
OIG Semiannual Report to Congress Highlights Fraud Recoveries
By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG released its Semiannual Report to Congress detailing its program integrity and oversight activities for the second half of the 2015 fiscal year (April to September) and highlighting its...